Biotech
Exact Sciences
Exact Sciences raises $125M Series D at $1.5B valuation
$125M
Total Raised
Series D
Latest Round
1995
Founded
5000+
Employees
Madison, WI
1 min read
Quick Facts
Valuation
$1.5B
Latest Round Size
$125M
Latest Round Date
February 2015
Exact Sciences: Series D Funding Round
Exact Sciences has successfully raised $125M in Series D funding, reaching a valuation of $1.5B.
Company Overview
Cancer screening and diagnostics
Funding Details
The Series D round was led by Casdin Capital, with participation from Fidelity.
Company Information
- Headquarters: Madison, WI
- Founded: 1995
- Employees: 5000+
- Category: Biotech
Investment
Exact Sciences plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Casdin Capital: Verified investor in Series D
- Fidelity: Verified investor in Series D
Key Investors
Casdin Capital
Lead Investor
Verified investor in Series D
Fidelity
Investor
Verified investor in Series D
About the Author
Editorial Team
Curated funding news from verified sources
Related Company Reports
Biotech
Orna Therapeutics
Orna Therapeutics Raises $251M Series B
Biotechnology company developing circular RNA therapeutics for cancer, genetic diseases, and infectious diseases
Emma Rodriguez
Oct 23, 2025
0 min read•$251M Series B
Biotech
Forge Biologics
Forge Biologics Raises $120M Series C
Gene therapy CDMO providing manufacturing and development services for AAV-based genetic medicines
Sarah Kim
Oct 23, 2025
0 min read•$120M Series C
Biotech
Vir Biotechnology
Vir Biotechnology Raises $250M
Clinical-stage immunology company developing treatments for infectious diseases including COVID-19, hepatitis B, and influenza
Sarah Kim
Oct 23, 2025
0 min read•$250M